18th November 2019

Rowing athlete receives sanction

The Australian Sports Anti-Doping Authority (ASADA) today acknowledged the decision of Rowing Australia to impose a four-year ban on athlete Jacob Richards for the presence of a metabolite of a prohibited substance and use of a prohibited substance. Mr Richards returned an Adverse Analytical Finding (AAF) from an out-of-competition doping control test during an U23 Australian Rowing Selection Camp on 20 June 2018.

His sample was analysed at the Australian Sports Drug Testing Laboratory, part of the National Measurement Institute, which detected the presence of Di-Hydroxy LGD-4033 (metabolite of LGD-4033). LGD-4033, originally developed for the treatment of muscle wasting conditions such as aging, osteoporosis, muscular dystrophy and cancer, is promoted as a selective non-steroidal anabolic agent.

It is claimed to be a substance that induces muscle (and bone) growth without the side effects associated with steroid use. However, information on the safety of LGD-4033 is scarce due to a lack of medium and long-term clinical trials – hence the medium and long-term health impacts are unknown.

It should be noted that a number of SARMs have associated health-risks, particularly for the heart and liver. Rowing Australia imposed a four-year ban on Mr Richards commencing on 20 June 2018. Mr Richards will be eligible to return to competition on 20 June 2022.

• This media release was published by the Australian Sports Anti-Doping Authority (ASADA) on 18 November 2019. Click here for the original.

You may also like...

Pin It on Pinterest

Share This